title: Ibrutinib: targeting the hidden CLL.
authors.affiliation: THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER.
authors.forename: Farrukh T
authors.identifier: http://orcid.org/0000-0003-1813-9812
authors.initials: FT
authors.lastname: Awan
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D049109:Cell Proliferation / Q000187:drug effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D016328:NF-kappa B / Q000276:immunology*; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D011947:Receptors, Antigen, B-Cell / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D016328:NF-kappa B; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; D011947:Receptors, Antigen, B-Cell; C551803:ibrutinib; D000225:Adenine